Lazarus Alon

CIK 00018082442 companiesWATERTOWN, MA

SEC Profile

Transactions

Companies

Filings

CIK

0001808244

Recent Transactions

18 trades

Award
Werewolf Therapeutics, Inc.$HOWL
Stock Option (right to buy)
2025-06-12+27,000→ 27,000 total
Award
Werewolf Therapeutics, Inc.$HOWL
Stock Option (right to buy)
2024-05-24+17,500→ 17,500 total
Award
Werewolf Therapeutics, Inc.$HOWL
Stock Option (right to buy)
2023-06-21+13,200→ 13,200 total
Award
Werewolf Therapeutics, Inc.$HOWL
Stock Option (right to buy)
2022-06-01+11,600→ 11,600 total
Purchase
Werewolf Therapeutics, Inc.$HOWL
Common Stock
2021-05-04$16.00/sh+400,000→ 2,046,634 total
Conversion
Werewolf Therapeutics, Inc.$HOWL
Series B Preferred Stock
2021-05-04−3,560,551→ 0 total
Conversion
Werewolf Therapeutics, Inc.$HOWL
Common Stock
2021-05-04+1,235,917→ 1,235,917 total
Conversion
Werewolf Therapeutics, Inc.$HOWL
Series A Preferred Stock
2021-05-04−10,714,284→ 0 total
Conversion
Werewolf Therapeutics, Inc.$HOWL
Common Stock
2021-05-04+410,717→ 1,646,634 total
Award
Werewolf Therapeutics, Inc.$HOWL
Stock Option (right to buy)
2021-04-30+23,200→ 23,200 total
Purchase
Werewolf Therapeutics, Inc.$HOWL
Series B Preferred Stock
2020-12-23$0.92/sh+3,560,551→ 3,560,551 total
Purchase
Keros Therapeutics, Inc.$KROS
Common Stock
2020-04-13$16.00/sh+120,000→ 2,013,102 total
Conversion
Keros Therapeutics, Inc.$KROS
Series A Preferred Stock
2020-04-13−1,382,295→ 0 total
Conversion
Keros Therapeutics, Inc.$KROS
Common Stock
2020-04-13+343,270→ 1,725,565 total
Conversion
Keros Therapeutics, Inc.$KROS
Common Stock
2020-04-13+1,382,295→ 1,382,295 total
Conversion
Keros Therapeutics, Inc.$KROS
Common Stock
2020-04-13+167,537→ 1,893,102 total
Conversion
Keros Therapeutics, Inc.$KROS
Series C Preferred Stock
2020-04-13−167,537→ 0 total
Conversion
Keros Therapeutics, Inc.$KROS
Series B-1 Preferred Stock
2020-04-13−343,270→ 0 total

Companies

Recent Filings

Address

C/O WEREWOLF THERAPEUTICS, INC. 200 TALCOTT AVENUE, 2ND FLOOR

WATERTOWN, MA, 02472

View on SEC.gov